SYNTHESIS OF VISCOSIN, A POTENTIAL THERAPEUTIC FOR CHAGAS' DISEASE

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$204,000.00
Award Year:
1987
Program:
SBIR
Phase:
Phase II
Contract:
n/a
Award Id:
4700
Agency Tracking Number:
4700
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Peptide Technologies Corp. (Currently Peptide Technolgies Corp.)
4970 Battery Lane, Suite 508, Bethesda, MD, 20814
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Terrence R Burke Jr
Principal Investigator
(202) 234-3384
Business Contact:
() -
Research Institution:
n/a
Abstract
THE ANTIBIOTIC VISCOSIN, A CYCLIC DEPSIPEPTIDE ISOLATED FROMPSEUDOMONAS VISCOSA, SHOWS PROMISING IN VITRO AND IN VIVO (MICE) CYTOTOXICITY AGAINST TRYPANOSOMA CRUZI, THE CAUSATIVEAGENT IN CHAGAS" DISEASE. THE TOTAL SYNTHESIS OF VISCOSIN IS PROPOSED IN ORDER TO CONFIRM ITS CHEMICAL STRUCTURE AND AND TO PROVIDE MATERIAL FOR RESEARCH. METHODS DEVELOPED DURING SYNTHESIS WILL BE USEFUL FOR FUTURE SYNTHESIS OF FRAGMENTS AND ANALOGS NECESSARY TO DETERMINE THE STRUCTURE- ACTIVITY RELATIONSHIPS OF THE COMPOUND. VISCOSIN AND RELATED COMPOUNDS REPRESENT A POTENTIAL CLASS OF CHEMOTHERAPEUTIC AGENTS FOR CHAGAS' DISEASE WHICH AT PRESENTIS AN INCURABLE AND POTENTIALLY FATAL DISEASE AFFECTING MILLIONS OF PEOPLE.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government